A Double-blind, Randomized, Placebo-controlled Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of Olpasiran (AMG 890) (a GalNAc conjugated Small Interfering RNA [siRNA]) in Subjects with Elevated Lipoprotein(a)
- Nicholls, Stephen (Primary Chief Investigator (PCI))
Project: Research